POLE and CTNNB1 marker sequencing. Offered by Genient Technologies as part of its expanded Oncology NGS portfolio.
A fastGEN cancer kit for laboratories evaluating POLE and CTNNB1 marker regions from isolated DNA.
A quick view of the product fit, marker scope, and workflow notes for laboratory planning.
RUO. Availability and intended use can vary by market; contact Genient for current guidance.
POLE, CTNNB1
Isolated DNA sequencing workflow support.
GENOVESA cloud workflow support for FASTQ analysis and reporting discussions.
Our team can help with assay selection, availability, implementation planning, and sequencing workflow fit.